| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |